Search results for: 'LIQUID BIOPSY MARKETS'

Healthcare is rapidly becoming patient-centric, focusing on outcomes and value. This offers clinical diagnostics players opportunities to advance their instrument, assay, and informatics capabilities to address unmet clinical needs and increase the precision diagnostics portfolio. Advances in next-generation sequencing-based companion diagnosti...

23 Aug 2022  |  North America  |  Frost Radar

Frost Radar™: US Liquid Biopsy, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

The oncology space is maturing rapidly. With the arrival of blood-based assays for cancer screening and the emphasis on early detection, the liquid biopsy segment is seeing increased consolidation and high-impact acquisitions, such as Illumina and GRAIL, Exact Sciences and Thrive Earlier Detection, and Roche Foundation Medicine and Lexent Bio. Comp...

09 Oct 2024  |  North America  |  Technology Research

Innovations and Growth Opportunities in the Biopsy Industry, 2024 2028

Exploring Recent Developments and Emerging Opportunities in Solid Tissue Biopsy and Breath Biopsy Thanks to Advancements in Precision, Automation, and Connectivity

Infographics

×

The biopsy device market s landscape is transforming due to technological advancements, evolving clinical needs, and the push for greater precision and minimally invasive approaches. In that context, this Frost & Sullivan analysis provides a comprehensive overview of different biopsy devices, with its main focus being solid tissue biopsy. In ad...

Liquid biopsy (CTCs and ctDNAs) is slowly gaining momentum in clinical care given its advantages over the traditional tissue-based gold standard methods. Short-term applications in cancer care range from risk assessment to cancer recurrence monitoring. Despite the proven advantages, there is still a significant number of barriers to adoption such a...

This research service encompasses a comprehensive analysis of minimally-invasive and non-invasive biopsy platforms that enable enhanced tumor profiling, treatment monitoring and precision oncology applications. This service primarily focuses on the use of circulating tumor DNA (ctDNA) circulating tumor cells (CTCs) and extracellular vesicles (EVs),...

The market for Ionic Liquids is gaining momentum in recent years mainly due to its capability for sustainable replacement of traditional organic solvents in many industrial applications. In certain industries, ionic liquids can also be considered as green chemistry as they reduce or eliminate the use and generation of hazardous substances in many ...

The study discusses key growth metrics and identifies the factors driving and restraining this market. It examines global industry trends from an end-user perspective and identifies the growth opportunities emerging from the changes in this space for market participants and stakeholders to leverage. The base year is 2023, and the forecast period is...

The APAC chromatography market is estimated to experience a CAGR of approximately 2.5% from 2019 to 2025, reaching $1,618.6 million. The objective of this study is to identify the key trends prevailing in the market in the base year 2019 and what factors boost and restrain market growth. In particular, it also discusses the product areas, vertical...

10 May 2018  |  North America  |  Market Research

Global Tissue Diagnostics Market, Forecast to 2022

Liquid Biopsy for Therapy Monitoring and Reimbursement Cuts Impede Long-term Prospects of Tissue Diagnostics Market

Infographics

×

Key Issues Addressed

Tissue diagnostic techniques are used to recognize specific antigens in preserved tissues. The process includes slicing thin tissue samples that are treated with a hematoxylin and eosin (H&E) stain, and then are formalin-fixed paraffin-embedded (FFPE) to diagnose tumors and other histopathology specimens. This has traditionally required skilled pat...